BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 28623159)

  • 1. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNAs: reflecting or affecting cardiovascular disease?
    van Empel VP; De Windt LJ; da Costa Martins PA
    Curr Hypertens Rep; 2012 Dec; 14(6):498-509. PubMed ID: 22996205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as biomarkers for clinical studies.
    Pogribny IP
    Exp Biol Med (Maywood); 2018 Feb; 243(3):283-290. PubMed ID: 28914096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease.
    Prestes PR; Maier MC; Woods BA; Charchar FJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of circulating microRNAs is expressed differently in patients with myocardial infarction.
    Liang J; Bai S; Su L; Li C; Wu J; Xia Z; Xu D
    Mol Med Rep; 2015 Jul; 12(1):243-7. PubMed ID: 25738515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
    Wang F; Chen C; Wang D
    Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epigenetic factors in atherogenesis: microRNA].
    Smirnova AV; Sukhorukov VN; Karagodin VP; Orekhov AN
    Biomed Khim; 2016; 62(2):134-40. PubMed ID: 27143369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
    Fichtlscherer S; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease.
    Benning L; Robinson S; Follo M; Heger LA; Stallmann D; Duerschmied D; Bode C; Ahrens I; Hortmann M
    J Vis Exp; 2018 Jul; (137):. PubMed ID: 30035774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.
    Tijsen AJ; Pinto YM; Creemers EE
    Am J Physiol Heart Circ Physiol; 2012 Nov; 303(9):H1085-95. PubMed ID: 22942181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.
    Li M; Zhang J
    Biomed Res Int; 2015; 2015():730535. PubMed ID: 26180810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases.
    Shi Q; Yang X
    J Cell Physiol; 2016 Apr; 231(4):751-5. PubMed ID: 26308238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcoronary concentration gradients of circulating microRNAs in heart failure.
    De Rosa S; Eposito F; Carella C; Strangio A; Ammirati G; Sabatino J; Abbate FG; Iaconetti C; Liguori V; Pergola V; Polimeni A; Coletta S; Gareri C; Trimarco B; Stabile G; Curcio A; Indolfi C; Rapacciuolo A
    Eur J Heart Fail; 2018 Jun; 20(6):1000-1010. PubMed ID: 29314582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations.
    Vegter EL; Ovchinnikova ES; van Veldhuisen DJ; Jaarsma T; Berezikov E; van der Meer P; Voors AA
    Clin Res Cardiol; 2017 Aug; 106(8):598-609. PubMed ID: 28293796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs expression profiles in cardiovascular diseases.
    Bronze-da-Rocha E
    Biomed Res Int; 2014; 2014():985408. PubMed ID: 25013816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Brief Review on the Biology and Effects of Cellular and Circulating microRNAs on Cardiac Remodeling after Infarction.
    Parikh M; Pierce GN
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases.
    Zhao Y; Song Y; Yao L; Song G; Teng C
    DNA Cell Biol; 2017 Feb; 36(2):77-94. PubMed ID: 28060535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.